Elevance Health, Inc. (elv)

ELV — Company Overview

Elevance Health, Inc. (ELV) trades on NYQ as part of the Healthcare peer group (Healthcare Plans).

ELV — Business Description

ELV represents a Healthcare Plans business in the Healthcare segment. Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery…

Official website: https://www.elevancehealth.com.

ELV — Investment Thesis

At a high level, ELV offers exposure to Healthcare with metrics outlined below from public market data.

• Revenue is expanding at roughly 1.4% year-over-year (public data).
• Trailing P/E of 17.79× sits in a moderate band relative to high-growth peers.
• Forward P/E (13.49×) is below trailing P/E — earnings may be expected to improve.
• Dividend yield near 1.7% adds an income component to total return.
• Equity market capitalization is approximately $86.44B.

See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.

ELV — Financial Health

Key financial health indicators for Elevance Health, Inc. are derived exclusively from public data — no proprietary estimates.

Profit margin near 2.5% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $4.31B supports balance-sheet flexibility.

ELV — Growth Outlook

Growth outlook for Elevance Health, Inc. (ELV) depends on demand trends in Healthcare Plans and the company's ability to convert revenue into sustainable earnings.

• Revenue growth of 1.4% suggests steady but measured expansion.
• Earnings declined -13.1% year-over-year — margin or volume pressure may be in play.
• Price is 8.6% below the 52-week high.

ELV — Competitive Position

Elevance Health, Inc. (ELV) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

• Competes within Healthcare, specifically in Healthcare Plans.
• Market capitalization of $86.44B places ELV among large-cap peers.
• Gross margin of 26.0% should be benchmarked against direct competitors.

ELV — Summary

Elevance Health, Inc. (ELV) is a large-cap Healthcare company focused on Healthcare Plans, listed on NYQ. Last price $398.56 with market cap $86.44B. Trailing P/E 17.79×. Revenue grew 1.4% year-over-year per public data. Notable strengths include positive free cash flow ($4.31b). Key watch items include earnings decline of -13.1% year-over-year. Premium Terminal tools for Elevance Health, Inc. add ownership analytics, news, and richer estimate history beyond this public summary.